Transaction · 0001415889-25-002135

Howe Jolanda

Howe Jolanda, SVP, CTRL, reported a transaction classified as exercise at Mirum Pharmaceuticals, Inc. involving 1500.000000 shares. Reported holdings after the transaction were 4426.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MSVP, CTRL
MIRMMirum Pharmaceuticals, Inc.
Filing timeJan 27
Trade dateJan 23, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

MIRM price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
MIRM since 2025-01-27Filed 585 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
exercise
Code M
Identifier
0001415889-25-002135
Common Stock
Transaction date
Jan 23, 2025
Filed Jan 27, 2025, 09:48 PM · 4d delay
Shares
1.50k sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
4.42k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase
-2score
Filing-only score

-2

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, GLOBAL CONTROLLER

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).

  2. F2

    Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.

  3. F3

    1/3rd of the shares subject to the restricted stock units vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year an…

Original filing · 0001415889-25-002135
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

MIRM